CEO Nick Reder, MD MPH on the Advantages of 3D Spatial Biology in Dynamk Capital interview

We were delighted to have Alpenglow CEO Nick Reder, MD MPH participate in this recent interview with Sebastien Latapie, Principal at Dynamk Capital.  3D spatial biology is an exciting new space and Dynamk wanted to learn more about how Alpenglow is using its technology to accelerate drug discovery.  Hear about the motivation for developing the technology, the advantages of 3D spatial biology over traditional 2D methods, applications, how AI is being applied to streamline use, and how we envision rolling this out broadly into the industry.   

Full Interview

Short Form